Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1295377.RAZgW9Yp8x4qz_rhxKalbAHcWfIQ1Wxdbg7D5qcQZOYO4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1295377.RAZgW9Yp8x4qz_rhxKalbAHcWfIQ1Wxdbg7D5qcQZOYO4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1295377.RAZgW9Yp8x4qz_rhxKalbAHcWfIQ1Wxdbg7D5qcQZOYO4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1295377.RAZgW9Yp8x4qz_rhxKalbAHcWfIQ1Wxdbg7D5qcQZOYO4130_provenance.
- NP1295377.RAZgW9Yp8x4qz_rhxKalbAHcWfIQ1Wxdbg7D5qcQZOYO4130_assertion description "[Bone metastases (BMs) are associated with poor outcome in metastatic clear-cell renal carcinoma (m-ccRCC) treated with anti-vascular endothelial growth factor tyrosine kinase inhibitors (anti-VEGFR-TKIs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295377.RAZgW9Yp8x4qz_rhxKalbAHcWfIQ1Wxdbg7D5qcQZOYO4130_provenance.
- NP1295377.RAZgW9Yp8x4qz_rhxKalbAHcWfIQ1Wxdbg7D5qcQZOYO4130_assertion evidence source_evidence_literature NP1295377.RAZgW9Yp8x4qz_rhxKalbAHcWfIQ1Wxdbg7D5qcQZOYO4130_provenance.
- NP1295377.RAZgW9Yp8x4qz_rhxKalbAHcWfIQ1Wxdbg7D5qcQZOYO4130_assertion SIO_000772 26528707 NP1295377.RAZgW9Yp8x4qz_rhxKalbAHcWfIQ1Wxdbg7D5qcQZOYO4130_provenance.
- NP1295377.RAZgW9Yp8x4qz_rhxKalbAHcWfIQ1Wxdbg7D5qcQZOYO4130_assertion wasDerivedFrom befree-2016 NP1295377.RAZgW9Yp8x4qz_rhxKalbAHcWfIQ1Wxdbg7D5qcQZOYO4130_provenance.
- NP1295377.RAZgW9Yp8x4qz_rhxKalbAHcWfIQ1Wxdbg7D5qcQZOYO4130_assertion wasGeneratedBy ECO_0000203 NP1295377.RAZgW9Yp8x4qz_rhxKalbAHcWfIQ1Wxdbg7D5qcQZOYO4130_provenance.
- befree-2016 importedOn "2016-02-19" NP1295377.RAZgW9Yp8x4qz_rhxKalbAHcWfIQ1Wxdbg7D5qcQZOYO4130_provenance.